How Lp(a) affects heart stent outcomes
Part of Heart & circulation clinical trials.
This study looks at a type of fat in your blood called Lp(a) and whether it can help predict how well people do after getting a heart stent (PCI). If you have stable heart disease and are scheduled for a planned stent procedure, joining this study would involve a blood test before the procedure to check your Lp(a) levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have stable heart disease and be scheduled for a planned stent procedure (not an emergency).
- You must agree to have blood drawn before your stent procedure.
- You cannot have had a heart attack or unstable chest pain in the last 30 days.
- You cannot be in cardiogenic shock or have had a heart transplant or a mechanical heart pump.
- You cannot be currently taking part in a blinded trial for a drug that lowers Lp(a).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a fatty substance in your blood called lipoprotein(a), or Lp(a), might affect the stiffness of your arteries and how well your heart muscle works. It will help us understand if high Lp(a) is connected to early signs of heart disease.
This study uses a heart CT scan to look for early signs of heart disease in first-degree relatives of people with high or low Lp(a). It aims to find hidden risks before symptoms start.
This trial tests ways to help doctors check for high Lp(a), a risk factor for heart disease, in patients who need it. The study looks at whether special strategies increase testing rates in cardiology centers that currently test less than 15% of eligible patients.
This study follows patients who had heart bypass surgery guided by special CT scans and blood flow measurements. Researchers want to understand how well the surgery works and study a blood protein called Lp(a) that may affect heart health.
This study looks at levels of a type of cholesterol called Lp(a) in people with certain heart and blood vessel diseases. The goal is to understand how common high Lp(a) is in Russian adults with these conditions.
This trial looks at how a type of fat in the blood called lipoprotein(a) and your body's ability to break down clots affect heart disease or heart valve disease. It is for people who are already taking certain cholesterol-lowering medicines or have severe aortic valve narrowing from calcium buildup.
Hear when a new PCI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.